Adherence to MHRA Guidelines for Valproate Prescribing in General Adult Psychiatry
Aims: Valproate is widely prescribed for psychiatric conditions, particularly bipolar disorder, but carries significant teratogenic risks. The Medicines and Healthcare products Regulatory Agency (MHRA) mandates strict prescribing guidelines, particularly for women of childbearing potential, to mitig...
Đã lưu trong:
| Tác giả chính: | |
|---|---|
| Định dạng: | Bài viết |
| Ngôn ngữ: | Tiếng Anh |
| Được phát hành: |
Cambridge University Press
2025-06-01
|
| Loạt: | BJPsych Open |
| Truy cập trực tuyến: | https://www.cambridge.org/core/product/identifier/S2056472425105863/type/journal_article |
| Các nhãn: |
Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| Tóm tắt: | Aims: Valproate is widely prescribed for psychiatric conditions, particularly bipolar disorder, but carries significant teratogenic risks. The Medicines and Healthcare products Regulatory Agency (MHRA) mandates strict prescribing guidelines, particularly for women of childbearing potential, to mitigate these risks. Additionally, emerging evidence suggests potential risks for men, including infertility and neurodevelopmental concerns. |
|---|---|
| số ISSN: | 2056-4724 |